Tenecteplase

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Tenecteplase belongs to the group of fibrinolytics. It is a recombinant variant or modification of the natural t-PA, which is characterized by three point mutations. Compared to t-PA, the fibrin specificity is 14 times higher. In addition, it has an 80 times higher resistance to the plasminogen activator inhibitor 1.

Dosage and method of useThis section has been translated automatically.

With a body weight between 60-69 kg: 35 mg, with 70-79 kg: 40 mg, with 80-89 kg: 45 mg, > 90 kg:050 mg as an i.v. bolus.

PreparationsThis section has been translated automatically.

Metalysis®

LiteratureThis section has been translated automatically.

  1. HA Neumann (2014) The coagulation system. ABW-Scientific Publisher GmbH Berlin

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer